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Nurse-Initiated Treatment Reduces Costs for Acute Asthma in a Pediatric
Emergency Department
Abstract
Standardized emergency department (ED) pathways can improve care delivery to children with acute
asthma, though their impact on hospitalization and costs is unclear. An Acute Asthma Care Pathway
(AACP) that facilitates nurse initiation of treatment was implemented at a tertiary care pediatric ED using
standard quality improvement methodology. The impact of implementation was assessed using process
control methodology and multivariable time series analyses between pre- and post-implementation
periods. Provision of a steroid within 30 minutes and 60 minutes of arrival increased by 21 and 22
percentage points respectively, IV magnesium sulfate administration increased by 30 percentage points,
the proportion hospitalized decreased from 44.8% to 32.2%, and mean direct costs per patient decreased
from $2,663 to $2,303 (13.5%). In multivariable analysis, these improvements remained significant.
Implementation of the AACP improved timeliness of treatment, hospitalization, and direct costs of
children receiving ED treatment for acute asthma.
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Introduction
Asthma is the most common chronic illness of childhood (Bloom et al., 2012). Hospitalization is a primary
driver of direct costs of asthma in children (Bahadori et al., 2009), contributing $3.9 billion of the $5.9 billion in
total pediatric asthma costs estimated in 2017 (Sullivan et al., 2017). Implementation of a standardized pathway
for emergency department (ED) treatment can reduce hospitalization of children with asthma (Gray et al., 2016)
but may not reduce costs. Prior implementations of standardized pathways either demonstrated reduced costs
using pre-post comparison (Johnson et al., 2018), or showed no effect using interrupted time series (ITS) analysis
(Rutman et al., 2016).
The ED described in this paper, at a tertiary care pediatric hospital serving the Intermountain West, has used an
asthma order set since 2002, based on and updated in alignment with national guidelines (National Asthma
Education and Prevention Program, 2007). In 2014, 45% of 985 children with a primary diagnosis of asthma (ICD9 493.xx) were hospitalized after treatment in this ED, almost double the median proportion among other U.S.
children’s hospitals that same year (24%) (Bourgeois et al., 2014). Hospital leadership prioritized reduction of
asthma admissions from the ED in alignment with the organizational goals of the healthcare system (James &
Savitz, 2011). In 2014, the hospital prioritized development and implementation of a new Acute Asthma Clinical
Pathway (AACP), with a goal to safely reduce the proportion of children hospitalized after treatment for acute
asthma in the ED.
The objective of this paper is to describe the implementation of an ED clinical pathway for children with acute
asthma and investigate the impact on care delivery and outcomes including direct costs.

Methods
Setting
This study was conducted at an urban tertiary care freestanding children’s hospital with 34 ED beds and
approximately 42,000 ED visits and 13,000 hospitalizations annually. The ED is staffed by pediatricians, pediatric
emergency medicine physicians, fellows, residents, nurse practitioners, nurses, and respiratory therapists (RTs).
Patients are seen according to nurse-assigned triage acuity by the next available provider, and clinicians are not
assigned to specific conditions or severities.
Planning the Intervention
In January 2015, the physician champion (MJ) and senior data analyst (MM) conducted an initial
investigation of ED asthma care quality including an evidence review, retrospective chart review of baseline care
delivery, interview of asthma quality directors at five other pediatric EDs with published pediatric asthma
pathways, and statistical analysis comparing this hospital’s ED performance to other pediatric EDs. They found
an opportunity for improvement in the timing of medication delivery and proportion of children hospitalized
after ED treatment.
Implementation Team
A multidisciplinary development team was formed including the ED Quality Improvement (QI) director
(ND) (Dudley et al., 2015), an ED nurse practitioner (AO), a QI project coordinator (LA), the nursing quality
director, an administrative sponsor familiar with prior improvements in asthma care delivery (Miescier et al.,
2005), a pediatric hospitalist experienced in inpatient asthma QI (Nkoy et al., 2015), and a data analyst. This
team developed the AACP beginning in March 2015 with input from ED clinicians, a hospital QI oversight
committee, pharmacists, and ICU and hospitalist physicians. The AACP addresses specific gaps in care delivery
including slow initiation of albuterol and steroid treatments, mismatch of care delivery timeliness with patient
severity, and underuse of intravenous magnesium sulfate (IVMg).
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Project Goal
The overall goal of the project was to reduce hospitalization without increasing returns after ED
discharge, while minimizing the adverse effects of cognitive bias (Russ et al., 2013) through development and
implementation of minimally complex clinical decision support, essential to overcome barriers to successful
guideline implementation (Cabana et al., 1999).

The Intervention
Description of the Acute Asthma Clinical Pathway
The AACP follows the structure of the Acute Care Model (Iyer et al., 2011) for ED care, by addressing
therapeutic reliability of interventions, diagnostic accuracy, segmentation of patients by risk, and accurate
disposition. The team compiled elements of the AACP into a single-page decision support tool for care delivery.
The AACP, outlined in Figure 1, includes the following elements:
1. Severity-based guidance for standardized medication delivery, based on previously published pathways
with significant reductions in hospitalization (Norton et al., 2007; Gildenhuys et al., 2009).
2. A multi-stage nurse-initiated standing order, previously shown to decrease time to treatment in asthma
(Zemek et al., 2012; Qazi et al., 2010), improving therapeutic reliability by ensuring timely treatment
regardless of ED crowding (Bekmezian et al., 2013). The AACP outlines an expanded role for nurses and RTs
to deliver medications by standing order using validated standardized assessments (Johnson et al., 2017; see
#6).
3. A standing order nested in a treatment algorithm that structures care delivery and patient disposition in a
clear graphical format. The AACP is integrated into workflow using a single form that can be initiated by a
triage nurse, delivering decision support at the time and location of decision-making by persisting on the
patient’s chart once selected by the triage nurse.
4. Simple screening questions used by nurses to identify patients for treatment (Sanders et al., 2007), a
diagnostic strategy at least as accurate as clinician judgment (Zemek et al., 2012).
5. Oral dexamethasone for any child with acute asthma and visible difficulty breathing. Timely administration
of steroids reduces hospitalization and ED length of stay (Rowe et al., 2001).
6. Treatment stratification according to patients’ hospitalization risk, a measure of validity used in the
development of clinical asthma scoring instruments (Bekhof et al., 2014). Local comparative data showed
that nurses’ application of the Emergency Severity Index (ESI) produced better segmentation by
hospitalization risk than any clinical asthma score obtained prior to ED treatment (Johnson et al., 2017).
7. Use of a standardized initial inhaled dose of albuterol and ipratropium for patients with hospitalization
risk of 40% or greater (ESI 1-3). Continuous dosing has improved efficacy over intermittent dosing in severe
asthma (Camargo et al., 2003) and minimizes delays. The efficacy of ipratropium in decreasing
hospitalization is well established (Griffiths & Ducharme, 2013).
8. Use of IVMg for any patient with hospitalization risk >80% (ESI of 1 or 2 on arrival [Parkin et al., 1996] or
clinical asthma score ≥4 after initial treatment), similar to inclusion criteria in trials that demonstrated
effect of IVMg on hospitalization (Shan et al., 2013).
9. All children with lower hospitalization risk (ESI 4-5) receive treatment beyond dexamethasone at
physician discretion, allowing flexibility in the choice and duration of treatment for children with low
hospitalization risk.
10. Standardized criteria for disposition after ED treatment allows time for ED treatment to improve asthma
symptoms prior to a disposition decision.
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Figure 1
One-Page AACP Decision Support Tool Used in Clinical Care

Implementation of the Acute Asthma Clinical Pathway
Implementation of the AACP was based on The Model for Improvement (Langley et al., 2009), a QI
methodology with proven utility in efforts to improve ED care delivery to children (Mahajan, 2011; Gray et al.,
2016). Following hospital approval, implementation began in March 2015 by presenting baseline data and planned
changes separately to ED, ICU, and Hospitalist physicians and staff. This data included graphical comparisons of
hospitalization for asthma at the hospital’s ED compared to other pediatric EDs (patient outcome), timing of
medication delivery according to patient severity (process measures), and variation in asthma hospitalization by
ED physician. Feedback from these meetings was used to refine the AACP. Baseline data was used to set entry
(one statistical deviation above the mean), target (80% within 60 minutes), and stretch (80% within 30 minutes)
goals for process measures.
Using clinicians’ suggestions, the data feedback plan focused on the proportion of eligible patients included in
the new process. Distribution of statistical process control (SPC) charts on process and control measures was
limited to the implementation team. The AACP recommends higher initial albuterol doses than was prior practice
for most patients, so strategies for consistent coding and billing were implemented so as to not interpret higher
dosing as higher acuity.
Outcome Measures and Data Collection
The institution’s enterprise data warehouse (EDW) was used to identify cases, defined as any ED visit in
a child 1-18 years old with a primary diagnosis of asthma (ICD-9 493.xx or ICD-10 J45.xx).
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The primary outcome measure included hospitalization from the ED and direct costs. Process measures included
timing of steroid delivery, timing of albuterol delivery, and use of IVMg. Patient severity was controlled for in
the analysis using baseline clinical characteristics including patient severity of illness (ESI), triage vital signs, and
history of ED, ICU, or hospital admission 12 months prior to the index visit. Balancing measures included ED length
of stay (LOS) and ED returns, defined as a visit with a diagnosis of asthma in any billed field to any facility in the
same healthcare network within 50 miles of the hospital for 7 days following discharge from the ED.
Three trained abstractors (MJ, AN, and CM) obtained patient-level data for secondary outcomes from
retrospective review of paper and electronic ED records, combining manually abstracted data with EDW data in
a secure REDCap database (Harris et al., 2009). All other data was obtained by electronic query from the EDW.
Direct costs include both variable and fixed costs and were adjusted for inflation using the Consumer Price Index
for Hospital Services in 2016 dollars.
Analyses
SPC charts and rules for special cause variation were used to assess change during process
implementation. SPC charts were generated using JMP Pro 14.0 (SAS Institute) with 3 sigma limits and centerlines
adjusted at major implementation timepoints.
For statistical analysis, all outcomes were compared between pre-implementation (June 2013-February 2015)
and post-implementation (June 2015-May 2016 for medication delivery and June 2015-May 2017 for
hospitalization) periods, excluding the implementation period (March 2015-May 2015). Timing of steroid and
albuterol were considered only in cases receiving those medicines during their ED treatment. The proportion of
cases receiving IVMg included all cases as the denominator. Finally, ED LOS was evaluated similarly to primary
outcomes. All outcomes were analyzed at the patient level except descriptive statistics on visit characteristics,
which were analyzed at the visit level.
Summary descriptive statistics of patient demographics and outcomes included mean and standard deviation for
continuous variables (assessed by Student’s t test) and counts and percentages for categorical variables (assessed
by Chi-square test). The intervention effect of AACP implementation was then assessed using an interrupted time
series (ITS) approach with multivariable generalized estimating equations (GEE). An ITS approach is helpful in
this situation because it can correct for overall time trends in outcomes while also controlling for patient-level
covariates. In GEE models, a logit link and binomial variance function was used for hospitalization and clinical
outcomes and a log link and gamma variance function for the cost outcome. Similarly, GEE with square root link
and Gaussian variance function was used for the hospital LOS. A p-value of 0.05 or less was used for statistical
significance. All analyses were performed using SAS 9.4 and STATA 12.1. Systolic hypotension was defined
according to age-based guidelines (Kleinman et al., 2010).
Ethical Considerations
A review by the institutional review board of the university affiliated with the children’s hospital
approved the project as a quality improvement initiative. All data was de-identified and there were no conflicts
of interest for any authors.

Results
Process Implementation
The clinical workflow for the AACP was refined using a one-week trial period in a small group of providers
and patients just prior to launch. The AACP was launched in June 2015 by stocking the single-page decision
support tool at the triage desk and sending an email notification to all providers. Brief role-specific descriptions
of the process change were attached to computer workstations for the first month following launch. Launch of
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the AACP was followed by a series of four Plan-Do-Study-Act (PDSA) cycles to embed the AACP into usual clinical
workflow.
The first PDSA cycle addressed a lack of familiarity among nursing staff with clinical asthma scoring, offering a
“scoring card” that each nurse submitted after simultaneously completing asthma scoring with an RT to receive
a chocolate bar (September 2015; Figure 2). The second PDSA cycle followed feedback that 20 mg albuterol
dosing caused unexpectedly long administration times, prompting simplification of drug choices (October 2015;
Figure 2). The third PDSA cycle followed nonattainment (69%) of the goal for steroid delivery within 60 minutes
(80%) in the first four months following launch. Frontline nurses identified lack of awareness of the AACP as a
possible cause, so the study team began a weekly system of recognition and reward (December 2015; Figure 2).
The ED team delivering steroid to a patient the fastest the preceding week was recognized in a group email and
received chocolate bars. This accompanied a sharp rise in the attainment of this goal from 77% to 90% within two
months (Figure 3). A fourth PDSA followed feedback from RTs that system-wide pharmacy policies did not allow
them to administer oral dexamethasone. The study team helped develop a policy in coordination with supportive
hospital leadership allowing RTs to administer oral dexamethasone in line with applicable state professional code
(April 2016; Figure 3). Over a 7-month period of intensive inclusion monitoring of all respiratory patients, 86% of
all intended patients were treated using the AACP.
Figure 2
Annotated P Chart of Proportion Hospitalized; Implementation of PDSA Cycles

2015)

(April 2016)

Launch into clinical workflow (June 2015)
Nurse scoring card (September 2015)
(October 2015)
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Figure 3
Annotated P Chart of Proportion with Steroid in 60 Minutes; Implementation of PDSA Cycles

Outcomes
For statistical analysis of all outcomes, the pre-implementation period from June 2013-February 2015
included a total of 1,648 visits from 1,290 unique patients. The post-implementation period included 1,833 visits
from 1,350 unique patients. Patient-level and visit-level characteristics are outlined in Table 1. Age, gender,
and payer types were comparable between pre- and post-implementation periods.
Primary Outcomes
The average uncontrolled proportion hospitalized was 44.8% pre-implementation and 32.2% in the postimplementation period (Table 2). In multivariable analysis this decrease in hospitalization was statistically
significant (risk difference -0.09, 95% CI -0.15 to -0.04, p=0.001; Table 3).
Direct Costs
The mean direct cost decreased from a baseline of $2,663 (SD $979; median $3,691) pre-implementation
to $2,303 (SD $950; median $3,825) in the post-implementation period (p=0.005; Table 2). These relationships
persisted in multivariable analysis, with the predicted direct cost of $517 less post-implementation (CI $61-$974;
p=0.026) compared to the pre-implementation period (Table 3).
Process and Balancing Measures
In unadjusted models, implementation of the AACP significantly increased the chance of children
receiving steroids and albuterol both within 30 and 60 minutes of arrival in the ED (Table 2). Delivery of IVMg
also increased by 30 percentage points. After controlling for patient characteristics, timely delivery of steroids
improved within 30 minutes (risk difference 0.08, 95% CI 0.03-0.14, p=0.003) and 60 minutes (risk difference
0.11, 95% CI 0.01-0.22, p=0.035), while the influence of implementation of the AACP on timely delivery of
albuterol was not statistically significant (30-minute risk difference 0.02, p=0.65; 60-minute risk difference 0.05,
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p=0.388; Table 3). Delivery of IVMg was also increased in multivariable analysis (risk difference 0.15, 95% CI 0.070.23, p<0.001; Table 3).
Uncontrolled mean ED LOS increased from 3.5 hours (SD 3.4 hours) to 3.8 hours (SD 3.6 hours), and
median ED LOS from 1.3 hours to 1.4 hours during the study period (Table 2), but this difference was not
significant in multivariable analysis (0.01 hours or 0.6 minutes increase, p=0.915 [Table 3]).
Table 1
Patient-Level and Visit-Level Characteristics Before and After AACP Implementation
Patient level (N=2640)
Age (months) (Mean;SD)
Gender (N;%)
Female
Male
Language preference (N;%)
English
Spanish
Others
Race (N;%)
White
Black
Native American/Pacific Islander
Asian
Unknown
Payer class (N;%)
Commercial
Government
Others (S)
Visit history (Mean;SD)
ED last 12 mo
Hospitalization last 12 mo
ICU last 12 mo
Visit level (N=3481)
Triage clinical values (Mean;SD)
HR (n=1503;1631)
RR (n=1498;1629)
SYSTOLIC (n=765;1482)
DIASTOLIC (n=762;1477)
SPO2 (n=1275;1417)
ESI (N;%)
1
2
3
4
5
Unknown
Triage SPO2 (N;%)
50-87
88-100
Unknown

Pre
n = 1,290
74 (47.6)

Post
n = 1,350
76 (49.9)

463 (35.9)
827 (64.1)

514 (38.1)
836 (61.9)

1152 (89.3)
7 (0.5)
131 (10.2)

1216 (90.1)
15 (1.1)
119 (8.8)

881 (68.3)
72 (5.6)
88 (6.8)
27 (2.1)

1029 (76.2)
83 (6.2)
125 (9.3)
34 (2.5)

222 (17.2)

79 (5.9)

620 (48.1)
587 (45.5)
83 (6.4)

656 (48.6)
631 (46.7)
63 (4.7)

358 (27.8)
320 (24.8)
77 (6)
Pre
n = 1,648

349 (25.9)
292 (21.6)
75 (5.6)
Post
n = 1,833

0.270
0.053
0.649

131 (25)
36 (13.2)
111 (11.5)
68 (10.4)
93 (4.6)

131 (27.1)
37 (13.8)
113 (12)
73 (10.8)
93 (4.4)

0.987
0.193
0.002
<.0001
0.955
0.066

85 (5.2)
495 (30)
894 (54.3)
167 (10.1)
5 (0.3)
2 (0.1)

72 (3.9)
487 (26.6)
1070 (58.4)
199 (10.9)
4 (0.2)
1 (0.1)

168 (10.2)
1107 (67.2)
373 (22.6)

152 (8.3)
1265 (69)
416 (22.7)

p-value
0.445
0.246

0.146

<.0001

0.137

p-value

0.146
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Table 2
Descriptive Statistics on Outcome Variables Before and After AACP Implementation
Pre-period
N = 1,648

Post-period
N = 1,833

Primary Outcomes
Hospitalization (N;%)
Adjusted total cost in 2017$ (Mean[SD];Median)

738
2,663 (979)

44.8%
3,691

590
2,303 (950)

Process and Balancing Measures
ED LOS in hours (Mean[SD];Median)

3.5 (3.4)

1.3

3.8 (3.6)

Returns after ED discharge (N;%)
50
Steroid (N;%)(N=1,648; 899)
1,240
Steroid in 60 min (N;%)(N=1,648; 899)
609
Steroid in 30 min (N;%)(N=1,648; 899)
234
Albuterol (N;%)(N=1,648; 899)
1,461
Albuterol in 60 min (N;%)(N=1,648; 899)
1,063
Albuterol in 30 min (N;%)(N=1,648; 899)
562
IVMG (N;%)(N=1,648; 899)
89
*p-values are from Chi-square test for categorical variables; t-test
⁺From Wilcoxon-Mann-Whitney test

Diff

p-value*

32.2%
3,825

-12.59
-360

<.0001
0.005;
0.083⁺

1.4

0.28

<.0001

0.01
0.03
0.22
0.21
0.00
0.07
0.05
0.33

0.205
0.138
<.0001
<.0001
0.865
<.0001
0.018
<.0001

3.0%
70
3.8%
75.2% 700
77.9%
37.0% 530
59.0%
14.2% 317
35.3%
88.7% 799
88.9%
64.5% 640
71.2%
34.1% 349
38.8%
5.4%
349
38.8%
for continuous variables

Table 3
Summary Table of Multivariable Analyses (N = 3,481)
Primary Outcomes
Hospitalization Rate
(Risk Diff, 95% CI)
Total Cost
(Cost Diff, 95% CI)
Process and Balancing Measures
ED LOS (hrs)
(LOS Diff, 95% CI)
Return (N=3,447)
(Risk Diff, 95% CI)
Steroid (N=2,547)
(Risk Diff, 95% CI)
Steroid in 60 min (N=1,925)
(Risk Diff, 95% CI)
Steroid in 30 min (N=1,925)
(Risk Diff, 95% CI)
Beta (N=2,547)
(Risk Diff, 95% CI)
Beta in 60 min (N=2,547)
(Risk Diff, 95% CI)
Beta in 30 min (N=2,547)
(Risk Diff, 95% CI)
IVMg (N=2,547)
(Risk Diff, 95% CI)

https://digitalcommons.library.tmc.edu/uthoustonjqualsafe/vol5/iss1/3

ME/OR (CI)

p-value

-0.09 (-0.15, -0.04)

0.001

-517 (-974, -61)

0.026

0.01 (-0.18, 0.2)

0.915

0 (-0.02, 0.02)

0.874

-0.02 (-0.12, 0.09)

0.718

0.11 (0.01, 0.22)

0.035

0.08 (0.03, 0.14)

0.003

0.02 (-0.04, 0.08)

0.458

0.05 (-0.06, 0.16)

0.388

0.02 (-0.06, 0.1)

0.650

0.15 (0.07, 0.23)

<0.001
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Discussion
A nurse-initiated ED care process improved delivery of albuterol, steroid, and IVMg, though only steroid
and IVMg improvements were statistically significant in multivariable analysis. Using process control
methodology, implementation of the AACP produced a sustained reduction in hospitalization within 4 months of
implementation (See Figure 2), and this was statistically significant in time series analysis. Direct healthcare
costs for children presenting to the hospital’s ED with acute asthma fell by 19.4% following implementation.
Hospital Returns
Confidence that returns were rare and unchanged by the AACP is increased by inclusion of returns to
most local hospitals, ensuring reduced costs represent improvements rather than cost shifting to return visits at
other sites.
Improvements in Process and Outcome Measures
The AACP improved process, outcome, and financial measures, which do not always move in parallel.
Prior reports of increased use of IVMg (Rutman et al., 2016), decreased ED length of stay (Rutman et al., 2016),
or reduced time to nebulized treatment (Qazi et al., 2009) did not also find reduced hospitalization of children
with asthma. Other published studies that improved the timing of treatment found reduced hospitalization of
children with asthma—from 27.5% to 13.5% with increased steroid administration and improved timing of
albuterol treatment (Norton et al., 2007), from 26.4% to 20.4% with improved timing of albuterol treatment
alone (Gray et al., 2016), and from 24% to 15% with improved timing of steroid administration alone (Brown et
al., 2012). Bhogal et al. (2012) found that administration of steroid within 75 minutes of arrival was associated
with a 15% relative reduction in odds of admission. We found that changes in the timeliness of albuterol treatment
following our improvements were not statistically significant. This may simply reflect a higher baseline
attainment of the albuterol-related process measures relative to steroid-related measures.
Timing of asthma treatment, especially the timeliness of steroid administration, is impactful on outcomes and
should be included in any efforts to analyze changes in asthma care delivery. Despite having evidence-based
order sets in the ED, there was room for improvement in care delivery, and a similar examination at any site is
likely to identify room for improvement. Building on the literature of quality improvement work in pediatric
emergency care, we add the valuable finding that efforts in improving ED asthma care for children reduced costs,
suggesting that comprehensive process change can produce direct and measurable economic impact.
Speed of Implementation
The success of the initiative is likely a result of three main factors: the AACP simplified care delivery
for providers, there was a comprehensive change in asthma care delivery, and a change that was implemented
intensively over a relatively short time frame. These factors likely discouraged providers from maintaining prior
behavioral patterns of care delivery. Improvements persisted 6 months after all individual feedback was stopped,
suggesting that improvements are facilitated and maintained by the AACP rather than simply due to Hawthorne
effect (Grimshaw & Russell, 1993). More detailed understanding of the causal impact of the AACP or components
of the AACP on outcome measures will require implementation in more diverse institutional settings.
Human Factors and Nurse Initiation
The AACP challenges the view that ideal patient outcomes are driven by an individual physician crafting
a unique yet optimal therapeutic plan customized for each patient. The workflow formalized by the AACP shifts
much of the work of identifying patients and selecting treatment to an interdisciplinary team including nurses
and RTs. Treatment initiation on arrival to the ED improves the therapeutic reliability of interventions by
minimizing the effects of ED crowding on quality (Bekmezian et al, 2013; Sills et al., 2011). Treatment is directed
to patients using validated instruments rather than individual calculations for each patient. This recognizes that
ED clinicians work in an environment prone to promote cognitive errors that affect treatment choices and patient
outcomes (Croskerry, 2003).
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Limitations
Over the study period, 16% of patients treated using the AACP did not have a primary diagnosis of asthma,
suggesting that in some patients the primary billing code may not reflect the clinical impression of asthma at the
time of ED treatment. No longitudinal changes were made that affect coding practices, making it unlikely that
this misclassification would affect these findings.
This study was not designed to calculate the total cost of asthma treatment, which includes direct and indirect
costs. Many children with acute asthma have significant symptoms after ED discharge (Stevens & Gorelick, 2001).
The indirect costs of these symptoms are significant (Szefler et al., 2011) and should be considered in the design
of future studies.
Conclusions
This paper described the development and impact of an Acute Asthma Care Pathway (AACP) implemented
in an ED for children with acute asthma on care delivery and outcomes, including direct costs. Provision of a
steroid within 30 minutes and 60 minutes of arrival increased by 21 and 22 percentage points respectively, IV
magnesium sulfate administration increased by 30 percentage points, the proportion hospitalized decreased from
44.8% to 32.2%, and mean direct costs per patient decreased from $2,663 to $2,303 (13.5%). These improvements
remained significant in multivariable analysis. Implementation of the AACP improved timeliness of treatment,
hospitalization, and direct costs of children receiving ED treatment for acute asthma.
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